Bispecific antibody drug conjugatesAntibody drug conjugatesBispecific antibodyTargeted therapySafetyHER2EGFR
国家自然科学基金Sichuan Science and Technology Program,ChinaSupport Program of Science and Technology Department of Sichuan Provincial,ChinaSupport Program of Science and Technology Department of Sichuan Provincial,China
820733182019YFS00032023YFSY00462022NSFSC1365
2024